<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00757107</url>
  </required_header>
  <id_info>
    <org_study_id>GBMET.CR.ROWEU1</org_study_id>
    <nct_id>NCT00757107</nct_id>
  </id_info>
  <brief_title>Taperloc Versus Taplerloc Microplasty</brief_title>
  <official_title>Clinical Evaluation of Taperloc Total Hip System With Two Different Stem Lengths</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ingemar Ivarsson</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biomet U.K. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This evaluation is conducted to evaluate the safety and performance of two different stem
      lengths of the Taperloc Total Hip System. Per implant bone loss and migration of the stem are
      compared between the two groups with Dual-energy X-ray absorptiometry (DEXA) and
      radiostereomektric analysis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consecutive patients between 50 - 70 years diagnosed with primary osteoarthritis of the hip
      and eligible for total hip arthroplasty will be asked to participate in the study.

      Periprosthetic bone loss, migration of the components and clinical scores will be recorded
      prospectively at 3,6,12 and 24 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone remodelling, i e change in bone mineral density around the stem, as measured with dual energy x-ray absorptiometry (DEXA) [ Time Frame:</measure>
    <time_frame>bone mineral density (BMD) measured postoperatively at 2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Migration of stem components in six degrees of freedom and maximum total point motion measured with radiostereometric analysis</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical outcome measures with Harris Hip Score comparing patients receiving different stems.</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Clinical outcome measures with Womac Score comparing patients receiving different stems.</measure>
    <time_frame>3, 6, 12 and 24 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Taperloc Microplasty</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with primary osteoarthritis with Taperloc microplasty non inferiority</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Taperloc Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with primary osteoarthritis Taperloc standard</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Taperloc Microplasty</intervention_name>
    <description>primary total hip arthroplasty</description>
    <arm_group_label>Taperloc Microplasty</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Taperloc standard</intervention_name>
    <description>primary total hip arthroplasty</description>
    <arm_group_label>Taperloc Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients with primary osteoarthritis of the hip scheduled for THA.

          -  Suitable anatomy for both stems

          -  Willingness and ability to follow study-protocol

        Exclusion Criteria

          -  Malignancy or metastatic bone disease.

          -  Any other disease severely affecting bone and mineral metabolism

          -  Ongoing or previous treatment (within 5 years prior to inclusion) with steroids

          -  Ongoing or previous treatment (within 5 years prior to inclusion) with
             antiresorptives.

          -  Ongoing or previous treatment (within 5 years prior to inclusion) with
             immunosuppressive drugs.

          -  Ongoing or previous treatment (within 5 years prior to inclusion) with anticonvulsive
             therapy.

          -  Ongoing or previous treatment (within 5 years prior to inclusion) with hormonal
             therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingemar IVARSSON, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University hospital of Linkoping</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University hospital of Linkoping</name>
      <address>
        <city>Linkoping</city>
        <zip>581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <removed_countries>
    <country>Norway</country>
  </removed_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2008</study_first_submitted>
  <study_first_submitted_qc>September 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2008</study_first_posted>
  <last_update_submitted>March 11, 2016</last_update_submitted>
  <last_update_submitted_qc>March 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Ingemar Ivarsson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Short femoral stem</keyword>
  <keyword>Stress shielding</keyword>
  <keyword>Stem migration</keyword>
  <keyword>Implant Survival</keyword>
  <keyword>DEXA</keyword>
  <keyword>Radiostereometric analysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

